Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;14(4):433-444.
doi: 10.1177/19476035231166127. Epub 2023 Jun 22.

Knee Osteoarthritis: Clinical and MRI Outcomes After Multiple Intra-Articular Injections With Expanded Autologous Adipose-Derived Stromal Cells or Platelet-Rich Plasma

Affiliations

Knee Osteoarthritis: Clinical and MRI Outcomes After Multiple Intra-Articular Injections With Expanded Autologous Adipose-Derived Stromal Cells or Platelet-Rich Plasma

Miguel A Khoury et al. Cartilage. 2023 Dec.

Abstract

Objective: To directly compare clinical and MRI outcomes of multiple intra-articular injections of adipose-derived stromal cells (ASCs) or platelet-rich plasma (PRP) in patients with knee osteoarthritis (OA).

Design: We retrospectively compared 24-month outcomes in (1) 27 patients receiving 3-monthly intra-articular injections with a total of 43.8 million ASCs and (2) 23 patients receiving 3-monthly injections of 3-ml preparation of PRP. All patients had Kellgren-Lawrence grade 1, 2, or 3 knee OA with failed conservative medical therapy. The Numeric Pain Rating Scale (NPRS) scores; Knee injury and Osteoarthritis Outcome Score (KOOS) at baseline, 6, 12, and 24 months after the first injection; and the MRI Osteoarthritis Knee Score (MOAKS) at 12 and 24 months were considered as outcomes.

Results: No major complications occurred in any patient. Both groups significantly improved in pain NPRS score and KOOS at 6 months. At 12- and 24-month evaluations, the ASC group significantly decreased scores to a greater degree (P < 0.001) than the PRP group. MOAKS scores indicated a decrease in disease progression in the ASC group.

Conclusion: Both ASCs and PRP were safe and resulted in clinical improvement in patients with knee OA at 6 months; however, at 12 and 24 months, ASCs outperformed leukocyte-poor PRP in clinical and radiological outcomes.

Keywords: adipose-derived stromal cells; cartilage injury; intra-articular injection; osteoarthritic knee pain; stem cells.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
NPR and KOOS subscales (symptom improvement, pain improvement, sport and recreation). NPR = Numeric Pain Rating Scale; KOOS = Knee Injury and Osteoarthritis Outcome Score; ADL = activities of daily living; QoL = quality of life.
Figure 2.
Figure 2.
MRI Fat saturated coronal image BML, MOAKS grade 3 (left) and 2 (right) in the medial knee compartment (white arrow) and lateral MOAKS grade 3 osteophytes without modification (blue arrow) after 24 months ASCs injections.
Figure 3.
Figure 3.
MRI fat-saturated sagittal image evaluating articular cartilage injury, MOAKS grade 2 (Left) and 0 (right) in medial knee compartment, weight-bearing region (white arrow) after 24 months ASCs injections.
Figure 4.
Figure 4.
MRI fat-saturated signal coronal image evaluating the distance between femur and tibia. Notice the increase in distance after 24 months of ASC injection therapy. ASC = adipose-derived stromal cell.
Figure 5.
Figure 5.
White arrow pointing at initial MOAKS grade 1 articular cartilage injury and bone marrow lesion in a PRP-treated patient. MOAKS = MRI Osteoarthritis Knee Score; PRP = platelet-rich plasma.
Figure 6.
Figure 6.
White arrow pointing at cartilage and bone marrow lesion in an MOAKS grade 2 injury. Progression of lesion in a PRP-treated patient. MRI at 24-month follow-up. MOAKS = MRI Osteoarthritis Knee Score; PRP = platelet-rich plasma.

Similar articles

Cited by

References

    1. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-30. doi:10.1136/annrheumdis-2013-204763. - DOI - PubMed
    1. Thomas KS, Muir KR, Doherty M, Jones AC, O’Reilly SC, Bassey EJ. Home based exercise programme for knee pain and knee osteoarthritis: randomised controlled trial. BMJ (Clinical Research Ed). 2002;325(7367):752. doi:10.1136/bmj.325.7367.752. - DOI - PMC - PubMed
    1. Karelson MC, Jokihaara J, Launonen AP, Huttunen T, Mattila VM. Lower nationwide rates of arthroscopic procedures in 2016 compared with 1997 (634925 total arthroscopic procedures): has the tide turned. Br J Sports Med. 2021;55(18):1018-23. doi:10.1136/bjsports-2019-101844. - DOI - PMC - PubMed
    1. Liebs TR, Ziebarth K, Berger S. Randomized controlled trials for arthroscopy in degenerative knee disease: was conservative therapy appropriately tried prior to arthroscopy. Arthroscopy. 2018;34(5):1680-7. doi:10.1016/j.arthro.2017.12.016. - DOI - PubMed
    1. Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81-8. doi:10.1056/NEJMoa013259. - DOI - PubMed